文献速递糖尿病

关于HNF1A-MODY最常见致病变异表型后果的多代研究

A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
PubMed 文献 · Diabetologia · 2021-12-24

本研究为家系多代研究,比较12个家系中145名HNF1A p.(Gly292fs)杂合携带者与131名非携带者亲属,其中208人至少完成一次OGTT。携带者半数至23岁仍未患糖尿病、三分之一至33岁仍未患病、13%至50岁仍未患病,中位诊断年龄21岁;2型糖尿病多基因风险评分每升高1个标准差,预测诊断年龄提前3.2年。

要点

  • 携带者半数至23岁、三分之一至33岁、13%至50岁仍未患糖尿病,中位诊断年龄21岁。
  • 2型糖尿病多基因风险评分每升高1个标准差,预测诊断年龄减少3.2年。
  • OGTT中携带者血糖更高、血清胰岛素与C肽更低,且成人体重与BMI更低。

核心结论

  • HNF1A-MODY最常见致病变异p.(Gly292fs)不仅表现为高血糖和胰岛素缺乏,还表现为脂解增强和成人BMI明显降低。
  • 血清胰岛素比C肽更能区分携带者与非携带者。
  • 相当比例携带者在青年期之后才发生糖尿病。
  • 即使在单基因糖尿病个体中,多基因糖尿病风险也修饰糖尿病发病年龄。

研究设计与样本

  • 家系多代研究,比较HNF1A p.(Gly292fs)杂合携带者与非携带者亲属,不论糖尿病状态。
  • 二十余年间共12个家系145名携带者与131名非携带者参与,其中208人至少完成一次OGTT。
  • 评估2型糖尿病多基因风险评分、糖尿病发病年龄、体成分及OGTT期间血浆葡萄糖、血清胰岛素、胰岛素原、C肽、胰高血糖素和NEFA反应。

主要发现

  • 携带者半数至23岁仍未患糖尿病,三分之一至33岁仍未患病,13%至50岁仍未患病;中位诊断年龄21岁(IQR 17-35)。
  • 性别、BMI、胰岛素敏感性或父母携带状态对发病年龄均无显著影响。
  • 2型糖尿病多基因风险评分每升高1个标准差,预测诊断年龄减少3.2年。
  • OGTT期间携带者血浆葡萄糖水平高于非携带者,血清胰岛素和C肽水平低于非携带者。
  • 携带者较非携带者更瘦:采用首次成年测量,体重低5.0 kg(p=0.012),BMI低2.1 kg/m2(p=2.2 × 10-4)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Systematic studies on the phenotypic consequences of variants causal of HNF1A-MODY are rare. Our aim was to assess the phenotype of carriers of a single HNF1A variant and genetic and clinical factors affecting the clinical spectrum. METHODS: We conducted a family-based multigenerational study by comparing heterozygous carriers of the HNF1A p.(Gly292fs) variant with the non-carrier relatives irrespective of diabetes status. During more than two decades, 145 carriers and 131 non-carriers from 12 families participated in the study, and 208 underwent an OGTT at least once. We assessed the polygenic risk score for type 2 diabetes, age at onset of diabetes and measures of body composition, as well as plasma glucose, serum insulin, proinsulin, C-peptide, glucagon and NEFA response during the OGTT. RESULTS: Half of the carriers remained free of diabetes at 23 years, one-third at 33 years and 13% even at 50 years. The median age at diagnosis was 21 years (IQR 17-35). We could not identify clinical factors affecting the age at conversion; sex, BMI, insulin sensitivity or parental carrier status had no significant effect. However, for 1 SD unit increase of a polygenic risk score for type 2 diabetes, the predicted age at diagnosis decreased by 3.2 years. During the OGTT, the carriers had higher levels of plasma glucose and lower levels of serum insulin and C-peptide than the non-carriers. The carriers were also leaner than the non-carriers (by 5.0 kg, p=0.012, and by 2.1 kg/m2 units of BMI, p=2.2 × 10-4, using the first adult measurements) and, possibly as a result of insulin deficiency, demonstrated higher lipolytic activity (with medians of NEFA at fasting 621 vs 441 μmol/l, p=0.0039; at 120 min during an OGTT 117 vs 64 μmol/l, p=3.1 × 10-5). CONCLUSIONS/INTERPRETATION: The most common causal variant of HNF1A-MODY, p.(Gly292fs), presents not only with hyperglycaemia and insulin deficiency, but also with increased lipolysis and markedly lower adult BMI. Serum insulin was more discriminative than C-peptide between carriers and non-carriers. A considerable proportion of carriers develop diabetes after young adulthood. Even among individuals with a monogenic form of diabetes, polygenic risk of diabetes modifies the age at onset of diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Kettunen JLT, Rantala E, Dwivedi OP, et al. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY. Diabetologia. 2021. PMID: 34951657. doi:10.1007/s00125-021-05631-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。